ThirtyFiveBio Employee Directory
Biotechnology ResearchEngland, United Kingdom11-50 Employees
ThirtyFiveBio is a biotechnology research company based in Milton, England, focusing on understanding the human biology of GPR35 to develop small-molecule inhibitors intended for ulcerative colitis and other gastrointestinal diseases. Founded by experienced professionals in the pharmaceutical industry and biotech entrepreneurship, the company operates from Oxford roots and aims to address GI conditions through targeted molecular intervention. Its work positions it within the biopharma sector, pursuing first-in-class approaches that could offer new therapeutic options for patients with inflammatory bowel disease and related GI disorders. In addition to its platform science, ThirtyFiveBio has pursued collaboration and investment activity to advance its development program, with recent regional activity signaling engagement with strategic partners.
1-888-653-2347 
support@leadiq.com 
